Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,296 | Dovepress* | 10,173+ | 2,404 | 12,577 | |
PubMed Central* | 3,123 | 887 | 4,010 | ||
Totals | 13,296 | 3,291 | 16,587 | ||
*Since 2 September 2013 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar